Multi-agent Chemotherapy (e.g., Hyper-CVAD regimen)

Treatment for Acute lymphoid leukemia

Effectiveness
75%
Safety Score
25%
Clinical Trials
1
Participants
100K

Comparative Safety Scale(Higher is safer)

Cyanideโ˜ ๏ธ
Meth๐Ÿ’€
Cigarettes๐Ÿšฌ
Chemoโ˜ข๏ธ
Alcohol๐Ÿบ
Morphine๐Ÿ’Š
Antibiotics๐Ÿ’‰
Tylenol๐Ÿ’Š
Exercise๐Ÿƒ
Water๐Ÿ’ง
25
DangerousModerateSafe
Treatment Details
0
Multi-agent Chemotherapy (e.g., Hyper-CVAD regimen) Outcomes

for Acute lymphoid leukemia

Efficacy Outcomes
Overall Effectiveness
+75%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Multi-agent Chemotherapy (e.g., Hyper-CVAD regimen) in Acute lymphoid leukemia

Multicenter Study of Combined Chemotherapy and Transplantation for Adult ALL

NCT07059156RECRUITINGPHASE2, PHASE3
View Study
50 participants
INTERVENTIONAL
Taiyuan, China
Started: Jun 1, 2025